(Q45811781)

16 December 2017

title

Hepatic effects of lovastatin exposure in patients with liver disease: a retrospective cohort study (English)

1 reference

16 December 2017

author name string

Andrew L Avins

1

1 reference

16 December 2017

Michele M Manos

2

1 reference

16 December 2017

Lynn Ackerson

3

1 reference

16 December 2017

Wei Zhao

4

1 reference

16 December 2017

Rosemary Murphy

5

1 reference

16 December 2017

Theodore R Levin

6

1 reference

16 December 2017

Douglas J Watson

7

1 reference

16 December 2017

Peggy M T Hwang

8

1 reference

16 December 2017

Amy Replogle

9

1 reference

16 December 2017

Jeffrey G Levine

10

1 reference

16 December 2017

publication date

1 January 2008

1 reference

16 December 2017

published in

Drug Safety

1 reference

16 December 2017

volume

31

1 reference

16 December 2017

issue

4

1 reference

16 December 2017

page(s)

325-334

1 reference

16 December 2017

https://scigraph.springernature.com/pub.10.2165/00002018-200831040-00006

exact match

0 references

cites work

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis

1 reference

12 December 2020

Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

Suboptimal statin adherence and discontinuation in primary and secondary prevention populations.

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Statins and liver toxicity: a meta-analysis

1 reference

12 December 2020

The liver and lovastatin

1 reference

12 December 2020

Drug-induced liver injury: Hy's rule revisited

1 reference

12 December 2020

Cytochrome P450: new nomenclature and clinical implications

1 reference

12 December 2020

ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins

1 reference

12 December 2020

Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.

1 reference

12 December 2020

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia

1 reference

12 December 2020

Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes.

1 reference

12 December 2020

Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

An assessment of statin safety by hepatologists

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Evaluation of cases of severe statin-related transaminitis within a large health maintenance organization

1 reference

12 December 2020

Outcome and prognostic markers in severe drug-induced liver disease

1 reference

12 December 2020

Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period

1 reference

12 December 2020

The liver and statin drug therapy: uncertain navigation in the sea of risk-benefit

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

1 reference

12 December 2020

Confounding by contraindication in a nationwide cohort study of risk for death in patients taking ibopamine

1 reference

12 December 2020

Pravastatin in patients with nonalcoholic steatohepatitis: results of a pilot study

1 reference

12 December 2020

Long-term persistence in use of statin therapy in elderly patients

1 reference

12 December 2020

Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project

1 reference

12 December 2020

10.2165/00002018-200831040-00006

Identifiers

DOI

1 reference

16 December 2017

Dimensions Publication ID

0 references

1 reference

16 December 2017